Barbra Keck
Direttore Finanziario/CFO presso SMARTKEM, INC.
Patrimonio netto: 863 $ in data 31/05/2024
Profilo
Barbra C.
Keck is currently the Director at SmartKem Ltd.
and the Chief Financial Officer at SmartKem, Inc. She previously held positions such as Director-Teacher Programs at Muse Machine, Audit Assistant & Member-Auditing Practice at Deloitte & Touche LLP, Manager-Arts Series at the University of Dayton, General Manager at Bach Society of Dayton, Inc., Manager-Donor Relations & Communications at Young Audiences New York, and Dean at Zicklin School of Business.
She also served as the Chief Financial Officer at Deverra Therapeutics, Inc. and Chief Financial & Accounting Officer, Secretary at Delcath Systems, Inc. Ms. Keck obtained an undergraduate degree from the University of Dayton and an MBA from Baruch College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SMARTKEM, INC.
0.01% | 27/03/2024 | 100 ( 0.01% ) | 863 $ | 31/05/2024 |
Posizioni attive di Barbra Keck
| Società | Posizione | Inizio |
|---|---|---|
| SMARTKEM, INC. | Direttore Finanziario/CFO | 14/12/2022 |
SmartKem Ltd.
 SmartKem Ltd. Industrial SpecialtiesProcess Industries SmartKem Ltd. engages in the design, development, industrialization, and technology transfer of solution-deposited organic semiconductors for transistor backplanes. The company was founded by Steve Paul Kelly in 2009 and is headquartered in St. Asaph, the United Kingdom. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Barbra Keck
| Società | Posizione | Fine |
|---|---|---|
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Direttore Finanziario/CFO | 31/05/2020 |
| DELCATH SYSTEMS, INC. | Direttore Finanziario/CFO | 01/05/2020 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 04/12/2008 |
| Zicklin School of Business | Corporate Officer/Principal | 01/08/2008 |
| Young Audiences New York | Public Communications Contact | 01/05/2006 |
Formazione di Barbra Keck
| University of Dayton | Undergraduate Degree |
| Baruch College | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Bach Society of Dayton, Inc.
 Bach Society of Dayton, Inc. Miscellaneous Commercial ServicesCommercial Services Bach Society of Dayton, Inc. performs and conducts singing shows. The company was founded in 2002 and is headquartered in Dayton, OH. | Commercial Services |
| Young Audiences New York | |
| Muse Machine | |
| SmartKem, Inc. | |
SmartKem Ltd.
SmartKem Ltd. Industrial SpecialtiesProcess Industries SmartKem Ltd. engages in the design, development, industrialization, and technology transfer of solution-deposited organic semiconductors for transistor backplanes. The company was founded by Steve Paul Kelly in 2009 and is headquartered in St. Asaph, the United Kingdom. | Process Industries |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Barbra Keck
